Xarelto Lawsuit Cases In MDL Proceed Towards A Court Date

June 26, 2016 – – TheProductLawyers.com reports on the most recent actions in the litigation against the manufacturers of the new-generation anticoagulant, Xarelto. During the last months of 2015, the U.S. Judicial Panel on Multidistrict Litigation elected to combine the 2,800 cases alleging harm from the drug in order to streamline the legal process. They created multidistrict litigation (MDL) No. 2592, which will be presented in the Eastern District of Louisiana. Judge Eldon Fallon is overseeing the case.

Expected to begin early in 2017 are four bellwether trials. Four cases will be selected for trial by jury in order to observe the reaction of jurors to evidence and testimony pertinent to the MDL. The outcomes of these trials will then be applied to future trials. Although the first two bellwether trials will be heard in the Eastern District of Louisiana on February 6th and March 13th, respectively, the third and fourth cases have been relocated to other districts. They will be brought before the court on April 24th and May 30th of 2017.

Initially embraced as a wonder drug, the new-generation anticoagulant has since fallen in the opinions of both medical circles and the public. Xarelto has been the focus of increasing litigation over the past few years, in which several major trends in allegations have emerged. Plaintiffs in MDL No. 2592 claim that use of the drug places them at an elevated risk of suffering severe bleeding episodes, and that the drug companies were negligent in their duty to inform both patients and physicians of this risk.

The Philadelphia Court of Common Pleas has also consolidated lawsuits to create a mass tort program of 550 cases leveling charges against the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals. In sum, the number of cases represented by these two combined groups stands to reach 4,000. Those involved in the litigation expect that as the date for the first bellwether trial in the MDL case nears, additional plaintiffs will come forward to join the group.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60011011